Incidence of subsequent malignancies after total body irradiation-based allogeneic HSCT in children with ALL – long-term follow-up from the prospective ALL-SCT 2003 trial

Anna Eichinger(Ludwig-Maximilians-Universität München), Michael H. Albert(LMU Klinikum), Daniel Stachel(Friedrich-Alexander-Universität Erlangen-Nürnberg), Angela Wawer(München Klinik Schwabing), Christina Peters(Cancer Research Institute of the Slovak Academy of Sciences), Ingo Müller(Universität Hamburg), Kinan Kafa, Ansgar Schulz(University Hospital Ulm), Bernd Gruhn(Jena University Hospital), Peter Bader(Goethe University Frankfurt), Jörn‐Sven Kühl(Charité - Universitätsmedizin Berlin), Brigitte Strahm(University Medical Center Freiburg), Hedwig E. Deubzer(Berlin Institute of Health at Charité - Universitätsmedizin Berlin), Birgit Burkhardt(University Hospital Münster), Bjoern Soenke Lange(University Hospital Carl Gustav Carus), Martin G. Sauer, Roland Meisel(Düsseldorf University Hospital), Peter Lang(STZ eyetrial), Oliver Basu(Essen University Hospital), Johann Greil(German Center for Pediatric and Adolescent Rheumatology), Selim Corbacioglu(Unknown), Alexander Claviez, Tayfun Güngör, Ulrike Pöetschger(Friedrich-Alexander-Universität Erlangen-Nürnberg), Paul‐Gerhardt Schlegel, Evgenia Glogova(St Anna Children's Hospital), Carl-Friedrich Classen, Rita Beier(Medizinische Hochschule Hannover)
Leukemia
September 12, 2022
Cited by 26


Related Papers